Regulatory29 May 2026, 06:33 pm
Jeevan Scientific: No Deviation in Preferential Allotment Funds
AI Summary
Jeevan Scientific Technology Ltd reports no deviations or variations in the utilization of proceeds from its preferential allotment during the quarter and year ended March 31, 2026. The company confirms adherence to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Funds were allocated for capital expenditure, working capital, subsidiary support, acquisition of API/formulation units, and general corporate purposes. Audit committee and auditor comments are NIL.
Key Highlights
- Jeevan Scientific confirms no deviation in preferential allotment fund utilization.
- Report is for the quarter and year ended March 31, 2026.
- Funds utilized for capital expenditure, working capital, and acquisitions.
- Audit committee and auditors reported no comments on fund utilization.
- Total amount raised through preferential allotment was ₹3074 Lakhs.
Price Impact
More from JSTL